arrow_back Civic Audit
Share share

Tick Act Reauthorization: Reduced Funding for Vector-Borne Disease Programs

This act reauthorizes programs to combat tick-borne and other vector-borne diseases, but with reduced funding. This means the government will have less money for research, prevention, and treatment of these diseases from 2026 to 2030. This could impact the support available to local health departments and the overall strategy for addressing public health threats.
Key points
Reduced funding for national strategy and regional centers of excellence in vector-borne disease from $10 million to $8 million annually for fiscal years 2026-2030.
Decreased enhanced support for health departments addressing vector-borne diseases from $20 million to $19 million annually for fiscal years 2026-2030.
Changes to the composition of the Tick-Borne Disease Working Group, potentially affecting future initiatives.
article Official text account_balance Process page notifications_active Track this Bill
gavel
Status:
Introduced
Record your position for audit.
Why does your vote on bills matter?
It creates raw, undeniable proof. Civic Will provides the permanent data to verify the Government's loyalty towards its citizens (explained here). Start recording it now.
Additional Information
Print number: 119_S_2294
Sponsor: Sen. Collins, Susan M. [R-ME]
Process start date: 2025-07-15
System Note: Lustra is free, publicly auditable civic infrastructure, with full source code available on GitHub. You are reading sterilized legislative data, processed by our radical neutrality engine to strip political spin and retain factual mechanics. We process only official government data. Original documents remain the authoritative source, always verify them if you can.
Summarized by: gemini-2.5-flash-preview-05-20
Source data: api.congress.gov
AI work logs for this document launch

OFFICIAL LEGAL TITLE

Kay Hagan Tick Reauthorization Act

FREQUENTLY ASKED QUESTIONS

What is the official ID of this bill?

The official print number for this legislation is 119_S_2294.

Which chamber initiated this legislation?

This legislation was initiated in the Senate.

When did the legislative process begin?

The process officially started on 2025-07-15.

What are the main provisions?

Key points include:

  • Reduced funding for national strategy and regional centers of excellence in vector-borne disease from $10 million to $8 million annually for fiscal years 2026-2030.
  • Decreased enhanced support for health departments addressing vector-borne diseases from $20 million to $19 million annually for fiscal years 2026-2030.
  • Changes to the composition of the Tick-Borne Disease Working Group, potentially affecting future initiatives.
What is the specific legal status?

The current status is Introduced.

Where can I read the full text of this legislation?

The full official text is available at: View full text

Who is the primary sponsor?

The primary sponsor is Sen. Collins, Susan M. [R-ME].

What is the latest detailed status?

The latest detailed status is: Introduced in Senate

Is this summary verified?

Yes. This content was analyzed by AI and verified by the Lustra Judge System on 2025-12-23.

What is the impact of this bill?

We don't know, that is up to you to decide. Summarizing raw data with AI is fundamentally different from predicting socio-economic outcomes. As of 2026, we believe impact assessment strictly requires a human in the loop to verify and judge.

CATEGORIES

Health